Dose-ranging study of riluzole in amyotrophic lateral sclerosis
Philippe Guillet(Ministère de la Culture), P. Nigel Leigh(Sorbonne Université), Vincent Meininger(Générale de Santé), Lucette Lacomblez(Sorbonne Université), Gilbert Bensimon(Pitié-Salpêtrière Hospital)
Cited by 1,290
Related Papers
A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
|New England Journal of Medicine|1994|2.2k
TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis
|Nature Genetics|2008|1.5k
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis
|Nature Genetics|2016|627
Clinical consequences of corticectomies involving the supplementary motor area in man
|Journal of the Neurological Sciences|1977|561